Anemia is a complication with impact on morbidity and mortality in chronic kidney disease (CKD) patients. Current markers
for the diagnosis and monitoring of anemia in CKD are limited by the interrelation between erythropoiesis, iron stores, inflammation,
and the resistance to treatment with erythropoiesis stimulant agents (ESA). The purpose of this presentation is to address the reticulocyte parameters Immature Reticulocyte Fraction (IRF) and Hemoglobin Concentration in Reticulocytes (RET-He), in particular in the monitoring of patients with CKD and in peritoneal dialysis

- Journal
- Articles
- Author Center
- Society
Editorial Board
The ESMED Editorial Board is comprised of experts from around the world.
Meet the community
See what our members have been working on.
Membership
Join ESMED for access to member-only content, congress discounts, and more.
- Policy